rs7332120

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.651+69C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.255 in 1,378,090 control chromosomes in the GnomAD database, including 47,536 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5496 hom., cov: 32)
Exomes 𝑓: 0.25 ( 42040 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.454

Publications

4 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 13-110209323-G-A is Benign according to our data. Variant chr13-110209323-G-A is described in ClinVar as Benign. ClinVar VariationId is 1293045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001845.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
NM_001845.6
MANE Select
c.651+69C>T
intron
N/ANP_001836.3
COL4A1
NM_001303110.2
c.651+69C>T
intron
N/ANP_001290039.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
ENST00000375820.10
TSL:1 MANE Select
c.651+69C>T
intron
N/AENSP00000364979.4
COL4A1
ENST00000543140.6
TSL:1
c.651+69C>T
intron
N/AENSP00000443348.1
COL4A1
ENST00000650424.2
c.651+69C>T
intron
N/AENSP00000497477.2

Frequencies

GnomAD3 genomes
AF:
0.265
AC:
40174
AN:
151850
Hom.:
5488
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.269
Gnomad AMI
AF:
0.0618
Gnomad AMR
AF:
0.319
Gnomad ASJ
AF:
0.244
Gnomad EAS
AF:
0.0458
Gnomad SAS
AF:
0.212
Gnomad FIN
AF:
0.320
Gnomad MID
AF:
0.242
Gnomad NFE
AF:
0.266
Gnomad OTH
AF:
0.231
GnomAD4 exome
AF:
0.253
AC:
310758
AN:
1226122
Hom.:
42040
AF XY:
0.253
AC XY:
156962
AN XY:
620660
show subpopulations
African (AFR)
AF:
0.268
AC:
7373
AN:
27514
American (AMR)
AF:
0.325
AC:
12417
AN:
38164
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
5605
AN:
23800
East Asian (EAS)
AF:
0.0321
AC:
1240
AN:
38668
South Asian (SAS)
AF:
0.227
AC:
17405
AN:
76690
European-Finnish (FIN)
AF:
0.313
AC:
16542
AN:
52930
Middle Eastern (MID)
AF:
0.256
AC:
1332
AN:
5200
European-Non Finnish (NFE)
AF:
0.259
AC:
236057
AN:
910738
Other (OTH)
AF:
0.244
AC:
12787
AN:
52418
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
11035
22069
33104
44138
55173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7210
14420
21630
28840
36050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.265
AC:
40218
AN:
151968
Hom.:
5496
Cov.:
32
AF XY:
0.266
AC XY:
19775
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.269
AC:
11161
AN:
41428
American (AMR)
AF:
0.320
AC:
4884
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.244
AC:
845
AN:
3470
East Asian (EAS)
AF:
0.0455
AC:
235
AN:
5168
South Asian (SAS)
AF:
0.213
AC:
1026
AN:
4820
European-Finnish (FIN)
AF:
0.320
AC:
3380
AN:
10552
Middle Eastern (MID)
AF:
0.247
AC:
72
AN:
292
European-Non Finnish (NFE)
AF:
0.266
AC:
18077
AN:
67934
Other (OTH)
AF:
0.228
AC:
482
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1524
3048
4571
6095
7619
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.278
Hom.:
753
Bravo
AF:
0.262
Asia WGS
AF:
0.133
AC:
465
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
1.4
DANN
Benign
0.17
PhyloP100
-0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7332120; hg19: chr13-110861670; COSMIC: COSV65423074; API